Sharp (6753 JT)
- Co.’s talks with Foxconn said to end March 26 without deal; considers capital increase to repay bonds. (Sankei)
Takeda Pharmaceutical (4502 JT)
- Co and Affymax recalled anemia treatment for kidney dialysis patients after reports of fatal reactions.
24 Feb 2013 - 23:33 - Equities - Source: Newswires
RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: